People who typically use LapSim, EndoSim, TeamSim, or other similar types of surgery simulation are medical students in training to become surgeons, doctors, nurses, etc. These technologies in particular have been proven to raise students testing average by 8% > .05% while the mean was typically around 4.3%.
Surgical Science produces the LapSim, TeamSim, EndoSim, and other simulations selling them in most countries to train future surgeons.
Features of these products include high definition graphics coupled with a cognitive system that allows simulations to be completely customizable for the user.
Functionality of these products, while generally are purposed toward creating a 'surgery' real enough to train students, change with the model. Using the example simulations picked the EndoSim is typically a less tangible version of the LapSim, and TeamSim serves the purpose of training students in group settings.
While researching surgery simulations it peeked my interest in what competition for this field of marketing would look like, and after conducting research it was apparent that the competition for this type of surgery simulation was at large in the age of modern technology.
CAE Healthcare, the creator of these simulations, works with Ascentium Capital to allow customer financing for their product to be flexible. Payment plans for their products are offered on purchases ranging $10,000 USD to $1.5 million USD.